Brief: Amniotics Q4 EBITDA at SEK -5 Million
22/02/2024 14:11
Feb 22 (Reuters) - Amniotics Q4 EPS SEK -4. * Q4 net income SEK -5.8 million * Q4 EBITDA SEK -5 million
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan